Stock search

Ticker or company name

Compare stocks

Market: US

  • BNYBNY Mellon
  • CMECME Group
  • ICEIntercontinental Exchange

Add stock

Ticker or company

Summary

BNY
BNY Mellon
$151,69Down −1,12%
Year: Up +36%

Not enough data for a score

Open stock page
CME
CME Group
$319,37Up +0,44%
Year: Up +12%
75/100Ratio would consider buying
Open stock page
ICE
Intercontinental Exchange
$178,29Down −0,12%
Year: Up +17%
89/100Best scoreRatio would consider buying
Open stock page

Verdict

ICE has the best score (89). CME grows revenue the fastest. BNY is the cheapest by forward P/E. CME has the lowest debt load. CME has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckBNY2 ✓ 0 — 0 ✕CME4 ✓ 4 — 0 ✕ICE7 ✓ 2 — 0 ✕
P/E vs its historyn/a15,825,824,0
P/E vs industry15,825,824,0
Forward P/E14,323,219,2
Revenue growth, YoYn/a—+9,0%+12,1%
EPS growth, YoYn/a—+18,1%+33,5%
Net marginn/a—n/a—29,6%
Net debt / EBITDAn/a—−0,52,7
Free cash flown/a—$4,33 bn$5,28 bn
Share count over a yearn/a—−0,5%−1,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBNYTTMCMETTMICETTMIndustry medianTTM
P/E TTM ↓Best: 15,8Worst: 25,824,024,0
Forward P/E ↓Best: 14,3Worst: 23,219,216,3
PEG ↓Best: 0,6Worst: 3,51,71,6
P/S TTM ↓n/aWorst: 9,0Best: 7,14,1
EV/EBITDA ↓n/aBest: 10,5Worst: 16,821,0
P/FCF ↓Best: 9,6Worst: 26,320,714,7

Price, %

  • BNYn/a
  • CMEn/a
  • ICEn/a

Returns

Best WorstNo mark — in between

PeriodBNYCMEICE
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BNYCMEICE
Share of “buy”67%Worst: 59%Best: 81%
Beat the forecastBest: 4 of 4Worst: 2 of 4Best: 4 of 4
Average “surprise”Best: +8,1%Worst: +0,1%+2,0%
Insiders over 12 monthssales $13,4 msales $35,7 msales $95,7 m

Details are on each stock page.